(IT) Gartner - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US3666511072
Stock:
Total Rating 40
Risk 94
Buy Signal -0.80
| Risk 5d forecast | |
|---|---|
| Volatility | 34.9% |
| Relative Tail Risk | -8.44% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -2.14 |
| Alpha | -82.63 |
| Character TTM | |
|---|---|
| Beta | 0.798 |
| Beta Downside | 0.505 |
| Drawdowns 3y | |
|---|---|
| Max DD | 73.73% |
| CAGR/Max DD | -0.30 |
EPS (Earnings per Share)
Revenue
Description: IT Gartner
Gartner, Inc. provides business and technology insights for decisions and performance on an organization's mission-critical priorities in the United States, Canada, Europe, the Middle East, Africa, and internationally. It operates through three segments: Insights, Conferences, and Consulting. The Research segment delivers insights through subscription services, such as access to published content, data and benchmarks, and direct access to a network of business and technology experts. The Conferences segment offers executives and teams in an organization the opportunity to learn, share, and network through its Symposium/Xpo series and peer-driven sessions, as well as conferences focused on specific business roles and topics. The Consulting segment provides technology-driven strategic initiatives, including custom analysis and on-the-ground support to senior executives. This segment also offers actionable solutions for IT-related priorities, including IT cost optimization, digital transformation, and IT sourcing optimization. Gartner, Inc. was founded in 1979 and is headquartered in Stamford, Connecticut.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 729.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA -1.67 > 1.0 |
| NWC/Revenue: -0.09% < 20% (prev 3.63%; Δ -3.72% < -1%) |
| CFO/TA 0.16 > 3% & CFO 1.29b > Net Income 729.2m |
| Net Debt (1.63b) to EBITDA (1.23b): 1.32 < 3 |
| Current Ratio: 1.00 > 1.5 & < 3 |
| Outstanding Shares: last quarter (72.1m) vs 12m ago -7.56% < -2% |
| Gross Margin: 67.66% > 18% (prev 0.68%; Δ 6698 % > 0.5%) |
| Asset Turnover: 78.19% > 50% (prev 73.43%; Δ 4.75% > 0%) |
| Interest Coverage Ratio: 16.98 > 6 (EBITDA TTM 1.23b / Interest Expense TTM 60.6m) |
Altman Z'' 4.44
| A: -0.00 (Total Current Assets 4.07b - Total Current Liabilities 4.07b) / Total Assets 8.09b |
| B: 0.83 (Retained Earnings 6.72b / Total Assets 8.09b) |
| C: 0.12 (EBIT TTM 1.03b / Avg Total Assets 8.31b) |
| D: 0.86 (Book Value of Equity 6.68b / Total Liabilities 7.77b) |
| Altman-Z'' Score: 4.44 = AA |
Beneish M -3.09
| DSRI: 0.98 (Receivables 1.73b/1.70b, Revenue 6.50b/6.27b) |
| GMI: 1.00 (GM 67.66% / 67.72%) |
| AQI: 0.99 (AQ_t 0.44 / AQ_t-1 0.45) |
| SGI: 1.04 (Revenue 6.50b / 6.27b) |
| TATA: -0.07 (NI 729.2m - CFO 1.29b) / TA 8.09b) |
| Beneish M-Score: -3.09 (Cap -4..+1) = AA |
What is the price of IT shares?
As of March 01, 2026, the stock is trading at USD 157.20 with a total of 2,141,534 shares traded.
Over the past week, the price has changed by +2.26%, over one month by -32.24%, over three months by -32.46% and over the past year by -68.01%.
Over the past week, the price has changed by +2.26%, over one month by -32.24%, over three months by -32.46% and over the past year by -68.01%.
Is IT a buy, sell or hold?
Gartner has received a consensus analysts rating of 3.55.
Therefor, it is recommend to hold IT.
- StrongBuy: 3
- Buy: 2
- Hold: 5
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the IT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 190.5 | 21.2% |
| Analysts Target Price | 190.5 | 21.2% |
IT Fundamental Data Overview February 28, 2026
P/E Trailing = 15.4871
P/E Forward = 20.9205
P/S = 1.7284
P/B = 12.7112
P/EG = 0.813
Revenue TTM = 6.50b USD
EBIT TTM = 1.03b USD
EBITDA TTM = 1.23b USD
Long Term Debt = 2.98b USD (from longTermDebt, last quarter)
Short Term Debt = 101.1m USD (from shortTermDebt, last quarter)
Debt = 3.35b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.63b USD (from netDebt column, last quarter)
Enterprise Value = 12.86b USD (11.23b + Debt 3.35b - CCE 1.72b)
Interest Coverage Ratio = 16.98 (Ebit TTM 1.03b / Interest Expense TTM 60.6m)
EV/FCF = 10.94x (Enterprise Value 12.86b / FCF TTM 1.18b)
FCF Yield = 9.14% (FCF TTM 1.18b / Enterprise Value 12.86b)
FCF Margin = 18.09% (FCF TTM 1.18b / Revenue TTM 6.50b)
Net Margin = 11.22% (Net Income TTM 729.2m / Revenue TTM 6.50b)
Gross Margin = 67.66% ((Revenue TTM 6.50b - Cost of Revenue TTM 2.10b) / Revenue TTM)
Gross Margin QoQ = 64.60% (prev 68.88%)
Tobins Q-Ratio = 1.59 (Enterprise Value 12.86b / Total Assets 8.09b)
Interest Expense / Debt = 0.57% (Interest Expense 19.1m / Debt 3.35b)
Taxrate = 22.85% (71.7m / 313.8m)
NOPAT = 793.6m (EBIT 1.03b * (1 - 22.85%))
Current Ratio = 1.00 (Total Current Assets 4.07b / Total Current Liabilities 4.07b)
Debt / Equity = 10.47 (Debt 3.35b / totalStockholderEquity, last quarter 319.9m)
Debt / EBITDA = 1.32 (Net Debt 1.63b / EBITDA 1.23b)
Debt / FCF = 1.38 (Net Debt 1.63b / FCF TTM 1.18b)
Total Stockholder Equity = 976.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.77% (Net Income 729.2m / Total Assets 8.09b)
RoE = 74.65% (Net Income TTM 729.2m / Total Stockholder Equity 976.7m)
RoCE = 26.02% (EBIT 1.03b / Capital Employed (Equity 976.7m + L.T.Debt 2.98b))
RoIC = 22.24% (NOPAT 793.6m / Invested Capital 3.57b)
WACC = 6.93% (E(11.23b)/V(14.58b) * Re(8.86%) + D(3.35b)/V(14.58b) * Rd(0.57%) * (1-Tc(0.23)))
Discount Rate = 8.86% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.47%
[DCF] Terminal Value 82.56% ; FCFF base≈1.26b ; Y1≈1.30b ; Y5≈1.46b
[DCF] Fair Price = 436.1 (EV 32.35b - Net Debt 1.63b = Equity 30.73b / Shares 70.5m; r=6.93% [WACC]; 5y FCF grow 3.16% → 2.90% )
EPS Correlation: 45.57 | EPS CAGR: 10.25% | SUE: 0.16 | # QB: 0
Revenue Correlation: 82.19 | Revenue CAGR: 9.14% | SUE: 0.47 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.91 | Chg7d=-0.003 | Chg30d=-0.163 | Revisions Net=-8 | Analysts=14
EPS current Year (2026-12-31): EPS=13.17 | Chg7d=-0.004 | Chg30d=-0.293 | Revisions Net=-4 | Growth EPS=-0.0% | Growth Revenue=+0.4%
EPS next Year (2027-12-31): EPS=14.51 | Chg7d=+0.025 | Chg30d=-0.370 | Revisions Net=-3 | Growth EPS=+10.2% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: -0.67 (2 Up / 10 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.4% (Discount Rate 8.9% - Earnings Yield 6.5%)
[Growth] Growth Spread = -3.0% (Analyst -0.6% - Implied 2.4%)
P/E Forward = 20.9205
P/S = 1.7284
P/B = 12.7112
P/EG = 0.813
Revenue TTM = 6.50b USD
EBIT TTM = 1.03b USD
EBITDA TTM = 1.23b USD
Long Term Debt = 2.98b USD (from longTermDebt, last quarter)
Short Term Debt = 101.1m USD (from shortTermDebt, last quarter)
Debt = 3.35b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.63b USD (from netDebt column, last quarter)
Enterprise Value = 12.86b USD (11.23b + Debt 3.35b - CCE 1.72b)
Interest Coverage Ratio = 16.98 (Ebit TTM 1.03b / Interest Expense TTM 60.6m)
EV/FCF = 10.94x (Enterprise Value 12.86b / FCF TTM 1.18b)
FCF Yield = 9.14% (FCF TTM 1.18b / Enterprise Value 12.86b)
FCF Margin = 18.09% (FCF TTM 1.18b / Revenue TTM 6.50b)
Net Margin = 11.22% (Net Income TTM 729.2m / Revenue TTM 6.50b)
Gross Margin = 67.66% ((Revenue TTM 6.50b - Cost of Revenue TTM 2.10b) / Revenue TTM)
Gross Margin QoQ = 64.60% (prev 68.88%)
Tobins Q-Ratio = 1.59 (Enterprise Value 12.86b / Total Assets 8.09b)
Interest Expense / Debt = 0.57% (Interest Expense 19.1m / Debt 3.35b)
Taxrate = 22.85% (71.7m / 313.8m)
NOPAT = 793.6m (EBIT 1.03b * (1 - 22.85%))
Current Ratio = 1.00 (Total Current Assets 4.07b / Total Current Liabilities 4.07b)
Debt / Equity = 10.47 (Debt 3.35b / totalStockholderEquity, last quarter 319.9m)
Debt / EBITDA = 1.32 (Net Debt 1.63b / EBITDA 1.23b)
Debt / FCF = 1.38 (Net Debt 1.63b / FCF TTM 1.18b)
Total Stockholder Equity = 976.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.77% (Net Income 729.2m / Total Assets 8.09b)
RoE = 74.65% (Net Income TTM 729.2m / Total Stockholder Equity 976.7m)
RoCE = 26.02% (EBIT 1.03b / Capital Employed (Equity 976.7m + L.T.Debt 2.98b))
RoIC = 22.24% (NOPAT 793.6m / Invested Capital 3.57b)
WACC = 6.93% (E(11.23b)/V(14.58b) * Re(8.86%) + D(3.35b)/V(14.58b) * Rd(0.57%) * (1-Tc(0.23)))
Discount Rate = 8.86% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.47%
[DCF] Terminal Value 82.56% ; FCFF base≈1.26b ; Y1≈1.30b ; Y5≈1.46b
[DCF] Fair Price = 436.1 (EV 32.35b - Net Debt 1.63b = Equity 30.73b / Shares 70.5m; r=6.93% [WACC]; 5y FCF grow 3.16% → 2.90% )
EPS Correlation: 45.57 | EPS CAGR: 10.25% | SUE: 0.16 | # QB: 0
Revenue Correlation: 82.19 | Revenue CAGR: 9.14% | SUE: 0.47 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.91 | Chg7d=-0.003 | Chg30d=-0.163 | Revisions Net=-8 | Analysts=14
EPS current Year (2026-12-31): EPS=13.17 | Chg7d=-0.004 | Chg30d=-0.293 | Revisions Net=-4 | Growth EPS=-0.0% | Growth Revenue=+0.4%
EPS next Year (2027-12-31): EPS=14.51 | Chg7d=+0.025 | Chg30d=-0.370 | Revisions Net=-3 | Growth EPS=+10.2% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: -0.67 (2 Up / 10 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.4% (Discount Rate 8.9% - Earnings Yield 6.5%)
[Growth] Growth Spread = -3.0% (Analyst -0.6% - Implied 2.4%)